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Abstract
Background: In Streptomyces coelicolor, bldA encodes the only tRNA for a rare leucine codon,
UUA. This tRNA is unnecessary for growth, but is required for some aspects of secondary
metabolism and morphological development. We describe a transcriptomic and proteomic analysis
of the effects of deleting bldA on cellular processes during submerged culture: conditions relevant
to the industrial production of antibiotics.
Results: At the end of rapid growth, a co-ordinated transient up-regulation of about 100 genes,
including many for ribosomal proteins, was seen in the parent strain but not the ΔbldA mutant.
Increased basal levels of the signal molecule ppGpp in the mutant strain may be responsible for this
difference. Transcripts or proteins from a further 147 genes classified as bldA-influenced were
mostly expressed late in culture in the wild-type, though others were significantly transcribed
during exponential growth. Some were involved in the biosynthesis of seven secondary
metabolites; and some have probable roles in reorganising metabolism after rapid growth. Many of
the 147 genes were "function unknown", and may represent unknown aspects of Streptomyces
biology. Only two of the 147 genes contain a TTA codon, but some effects of bldA could be traced
to TTA codons in regulatory genes or polycistronic operons. Several proteins were affected post-
translationally by the bldA deletion. There was a statistically significant but weak positive global
correlation between transcript and corresponding protein levels. Different technical limitations of
the two approaches were a major cause of discrepancies in the results obtained with them.
Conclusion: Although deletion of bldA has very conspicuous effects on the gross phenotype, the
bldA molecular phenotype revealed by the "dualomic" approach has shown that only about 2% of
the genome is affected; but this includes many previously unknown effects at a variety of different
levels, including post-translational changes in proteins and global cellular physiology.
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The extraordinary virtuosity of streptomycetes as produc-
ers of secondary metabolites, including most of the anti-
biotics and anti-cancer agents in wide use, is associated
with the developmental complexity of Streptomyces colo-
nies, which have a vegetative substrate mycelium and a
spore-bearing aerial mycelium. Among many mutants of
the model species Streptomyces coelicolor with pleiotropic
defects in both aspects, this paper focuses on a mutant
deleted for the bldA locus, which specifies the only tRNA
in the genome able to efficiently translate the rare leucine
codon UUA [1-3]. Since the complex bldA phenotype is
likely to involve elements of both transcriptional and
translational control, it is particularly suitable for an inte-
grated functional genomics approach. With the aim of dis-
covering consequences of bldA mutation that are not
obvious to the naked eye, we set out to analyse the RNA
and protein extracted from a series of liquid cultures of
isogenic bldA+ and bldA deleted strains. This allowed us to
focus on the effects of bldA deletion on metabolism and
overall cell physiology without the complication of the
unsynchronised morphological differentiation observed
with surface-grown S. coelicolor cultures. Our results
revealed unexpected effects of bldA mutation on gene
expression during growth and the transition phase that
precedes entry into stationary phase, as well as more wide-
ranging effects on secondary metabolism than previously
suspected, and led to further exploration of some of the
underpinning mechanisms. Different, but complemen-
tary, results were obtained with the two
"omic"approaches, and we conclude that there are signif-
icant benefits from their combined application.
Results
General characterisation of changes in the transcriptome 
and proteome during liquid culture of strain M600 ("wild-
type") and its bldA deletion derivative
Overall strategy
The genome sequence of S. coelicolor [4] had been deter-
mined with DNA from a widely-used plasmid-free deriva-
tive (M145) of the wild-type strain A3(2). We could not
use M145 for the work described here, because of the
unexpected finding that bldA mutants cannot readily be
constructed in M145 (M. Tao and KFC, unpublished;
Gehring et al. [5]). Instead, we used M600, a plasmid-free
prototrophic strain that was derived from the original
wild-type strain A3(2) by a minimally mutated route, and
has been used for physiological studies [6]. It proved
straightforward to construct a bldA deletion in M600.
Proteomic and transcriptomic analyses were done with
cultures grown in casaminoacid-supplemented liquid
minimal medium (SMM) to different stages (Fig. 1).
Material from each culture was divided into two parts,
which were processed separately for the extraction and
characterisation of protein and RNA. All transcriptome
experiments were done using three independent time
series for each strain (biological replicates), and two of
these replicate sets of samples were used for the proteomic
analysis. For transcriptome analysis, genomic DNA
labelled with Cy-5 dCTP was used as a common reference.
This strategy allows the magnitude of expression to be esti-
mated, rather than the relative expression level that is
obtained from 'direct comparison' cDNA vs cDNA hybrid-
isations. This enabled us to compare the level of transcript
for each gene with the abundance of its corresponding
protein product. The approach also allows transcriptome
data to be compared directly with other microarray data-
sets that use genomic DNA as the common reference.
However, two important caveats emerged in the course of
the work: first, for several technical reasons the microarray
data can be relatively compressed compared with results
from more gene-specific analytical procedures such as
quantitative RT-PCR or S1 nuclease protection; and sec-
ond, M600, used as the "wild-type" strain here, turned out
to have a duplication of the genes SCO0021-1004 com-
pared with the M145 DNA used as the microarray refer-
ence DNA [7]. This duplication may have had some direct
effects on levels of mRNA and proteins corresponding to
the duplicated genes, or indirect effects on genes else-
where in the genome, but it did not affect the validity of
the analysis of the effects of bldA deletion described in this
paper.
Although protein samples were taken at all the time-
points shown in Fig 1, the labour-intensiveness of 2-D gel
analysis led us to confine the proteomic experiments to
duplicate samples for each of five time-points (samples 1,
2, 4, 6 and 8), and to use high resolution 2-D gel separa-
tion only in the two pI ranges into which most proteins
fall (4.5 – 5.5 and 5.5 – 6.7). Among the proteins
excluded by this approach were integral membrane pro-
teins and extracellular proteins (both of which have been
analysed separately: [8,9]), proteins of less than ca.12 kDa
or more than ca.120 kDa, and those with a basic pI
(including many ribosomal proteins).
Detection of 74 differentially transcribed genes
For the transcriptome analysis, 5,983 genes remained for
comparison between the strains after filtering out genes
deemed to be 'non-changing' because they had log2
expression levels between -0.667 and 0.667 in all 16 time
points (eight in M600, eight in ΔbldA). Applying different
statistical approaches (see Methods), 74 genes – ~1% of
all genes – were differentially transcribed between the
wild-type and ΔbldA mutant at the specific thresholds
applied (Table 1 and see Additional File 1). Since previous
work has focussed on genes whose expression is reducedPage 2 of 22
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expression of 13 of the 74 genes was significantly
increased in the mutant strain (p-value < 0.05 and/or
probability of false prediction (pfp) < 0.1 for Welch t-test
and/or Rank Product analysis (see Methods) respectively).
In order to validate the differentially expressed gene list
independently, 14 of the 74 genes were also analysed by
quantitative real time PCR (Q-RT-PCR), including
SCO6638, one of two TTA-containing genes in the list of
74 genes (see Table 1 for list). The expression profiles gen-
erated by the two techniques were broadly in agreement
with each other, exhibiting Spearman correlation coeffi-
cients ranging from 0.54 to 0.91 (see Additional File 2).
Unexpected effects of bldA deletion at growth stages preceding 
stationary phase, leading to the discovery of abnormal ppGpp levels 
in the bldA mutant
Since bldA mutants grow well, but differ from the wild-
type most obviously in attributes expressed after the main
growth period (aerial growth and secondary metabolism
[10]), we expected to find effects of bldA deletion mainly
on stationary phase gene expression. While one-third of
the 74 differentially transcribed genes conformed to this
expectation, the rest did not (see Additional File 1): two
genes were most highly expressed during exponential
growth in the mutant strain (SCO3088 and the putative
RNA helicase gene SCO5166), 20 were consistently more
highly expressed during all phases of growth and a further
16, encoding elements of the translational apparatus,
showed a transient upshift at transition phase in the wild-
type but not in the mutant (Table 1, see Additional File 1
and illustrated in Fig. 2A). The tight transition phase-
dependent expression change of the latter genes has also
been seen in other wild-type strains (V. Mersinias, G.B.
and C.P.S., unpublished data). These observations suggest
that, in addition to its important role in stationary phase
biology, bldA may also influence transcription of certain
genes at earlier stages, either due to an involvement of
bldA in at least some exponential and transition phase
processes, or because of some indirect effect of the loss of
bldA on cellular physiology. Such indirect effects could
include a 'shadow' cast by effects of bldA on the formation
of the spores used to inoculate the cultures (inoculum
preparation is known to influence the behaviour of cul-
tures in industrial fermentations), or some kind of stress
response caused by the occupation of a proportion of
ribosomes by untranslatable UUA codon-containing RNA
(see below). For example, two of these genes (SCO4262
and SCO6638) contain TTA codons, and translation of
the transcripts detected is therefore dependent on bldA.
The identification of these genes as being significantly dif-
ferently expressed suggests that their transcript abun-
dance, in addition to their translation, is in some way
bldA-dependent. The 15 differentially expressed ribos-
omal protein genes listed in Table 1 mostly fall within one
cluster (SCO4701-SCO4721). Further members of this
and other ribosomal protein gene clusters appeared in the
top rankings of genes down-regulated in bldA compared
to M600 but did not meet the statistical threshold criteria
applied here. Similar extensive alterations in patterns of
protein abundance were not observed in the proteome
study, primarily because most of the ribosomal proteins
have isoelectric points that lie outside those used in the
analysis (see Additional File 3); but in any event the
observed modulations in transcription may not have
resulted in detectable changes in abundance of stable pro-
teins such as those making up ribosomes. However, com-
parable changes have been documented at the proteome
level in pulse-chase experiments, using a different
medium, by Vohradsky and Thompson [11].
The effects on transition-phase expression of ribosomal
protein-encoding genes raised the possibility that the
changes might be mediated via ppGpp, the stringent fac-
tor that controls transcription of rRNA and certain ribos-
omal protein operons in E. coli and many other bacteria,
including streptomycetes [6]. Previous studies had shown
that ppGpp concentrations increase transiently during
transition phase growth of S. coelicolor in SMM medium
[12]. Since ppGpp is synthesised when an insufficient
supply of aminoacyl-charged tRNAs causes translation to
stall, it was possible that stalling of ribosomes encounter-
ing a UUA codon during translation in a bldA mutant
Growth of S. coelicolor M600 and M600 ΔbldA in supple-mented minimal mediumFigure 1
Growth of S. coelicolor M600 and M600 ΔbldA in supple-
mented minimal medium. A schematic representation of the 
measured growth curves is shown with M600 denoted by a 
solid line, and M600 ΔbldA by a broken line. Points 1–8 indi-
cate times when cultures were harvested for RNA and pro-
tein extraction, and the shaded arrow represents the onset 
of pigmented antibiotic production in M600 (the mutant did 
not produce pigments). All eight sampling points were ana-
lysed transcriptomically, while only samples 1, 2, 4, 6 and 8 
were subjected to proteomic analysis.
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BMC Genomics 2007, 8:261 http://www.biomedcentral.com/1471-2164/8/261Table 1: Genes differentially expressed in the transcriptome data as a result of bldA mutation1
Gene2 Annotated function3 P-value4 Mean pfp 
value5
Up/down 
in bldA6
Potential reason for absence 
in proteomic data7
SCO0072 possible secreted protein N/A 0.055* down Secreted
SCO0247 conserved hypothetical 
protein
3.29E-06 N/A down Predicted 1 transmembrane 
domain
SCO0248 hypothetical protein 1.76E-05 N/A down Predicted pI = 11.6
SCO0297 secreted protein 8.25E-05 0.033 down Secreted
SCO0472 possible secreted protein N/A 0.076* down Secreted
SCO0499 possible formyltransferase 9.76E-04 N/A down
SCO0759 hypothetical protein 0.000976 N/A down Predicted 1 transmembrane 
domain
SCO0760 probable methyltransferase 0.000796 0.083 down Predicted pI = 10.9
SCO0762 protease inhibitor precursor 0.0262 0.012 down Secreted
SCO0990 integral membrane protein 7.72E-03 N/A down Predicted 7 transmembrane 
domains
SCO0991 conserved hypothetical 
protein
0.00772 N/A down Predicted transmembrane 
domain
SCO0994 integral membrane protein 0.0317 N/A down Predicted 9 transmembrane 
domains
SCO0995 probable methyltransferase 9.76E-04 N/A down Predicted 2 transmembrane 
domains
SCO1089 unknown N/A 0* up None
SCO1815 probable 3-oxacyl-(acyl-
carrier-protein) reductase
N/A 0.084* down Predicted 2 transmembrane 
domains
SCO1845 possible low-affinity 
phosphate transport protein
N/A 0* up Predicted 10 transmembrane 
domains
SCO1968 probable secreted hydrolase N/A 0* down Secreted
SCO2435 hypothetical protein 0.00589 N/A down None
SCO3088 hypothetical protein 0.000415 N/A up Predicted pI = 9.7, mwt = 
8377 Da
SCO3285 large gly/ala rich protein 7.72E-03 N/A up
SCO3286 secreted protein 0.00772 0.05 up Secreted
SCO3428 50S ribosomal protein N/A 0.082* down Predicted pI = 10.8, mwt = 
6416 Da
SCO3608 hypothetical protein N/A 0.1* up Predicted 3 transmembrane 
domains
SCO3717 probable cation transport 
system component
N/A 0.068 up Predicted 7 transmembrane 
domains
SCO3718 probable cation transport 
system component
N/A 0 up Predicted 11 transmembrane 
domains
SCO4131 integral membrane protein 0.0389 N/A down Predicted 2 transmembrane 
domains
SCO4173 unknown N/A 0.088* down Predicted 1 transmembrane 
domains
SCO4174 possible integral membrane 
protein
N/A 0.088* down Predicted 1 transmembrane 
domains; predicted pI = 11.0
SCO4187 putative membrane protein 0.0404 0.1 down Predicted pI = 9.5, mwt = 
6268 Da
SCO4246 hypothetical protein 5.89E-03 N/A down Predicted pI = 9.7
SCO4252 hypothetical protein 3.29E-06 0.017 down
SCO4253 conserved hypothetical 
protein
5.93E-05 5.66E-03 down
SCO4256 possible hydrolytic protein 0.00772 N/A down None
SCO4262 hypothetical protein 0.000976 0.083 down Predicted pI = 11.7, mwt = 
12884 Da
SCO4295 Cold shock protein scoF4 0.00126 0.053 down Predicted mwt = 7387 Da
SCO4442 hypothetical protein 0.00608 0.09* down Predicted mwt = 6484 Da
SCO4653 50S ribosomal protein N/A 0.097* down None
SCO4661 elongation factor G N/A 0.088* down None
SCO4677 possible regulatory protein N/A 0.038* downPage 4 of 22
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BMC Genomics 2007, 8:261 http://www.biomedcentral.com/1471-2164/8/261SCO4703 50S ribosomal protein N/A 0.076* down Predicted pI = 10.0
SCO4704 50S ribosomal protein N/A 0.044* down Predicted pI = 10.6
SCO4705 50S ribosomal protein N/A 0.087* down Predicted pI = 11.3
SCO4706 30S ribosomal protein N/A 0.095* down Predicted pI = 10.8
SCO4707 50S ribosomal protein N/A 0.091* down Predicted pI = 10.2
SCO4712 50S ribosomal protein N/A 0.087* down Predicted pI = 10.2
SCO4713 50S ribosomal protein N/A 0.076* down Predicted pI = 10.3
SCO4714 50S ribosomal protein N/A 0.088* down Predicted pI = 9.6
SCO4716 30S ribosomal protein N/A 0.077* down Predicted pI = 9.6
SCO4717 50S ribosomal protein N/A 0.043* down Predicted pI = 9.8
SCO4718 50S ribosomal protein N/A 0.074* down Predicted pI = 10.6
SCO4719 30S ribosomal protein N/A 0.071* down Predicted pI = 10.1
SCO4994 hypothetical protein 0.0136 N/A down Predicted 1 transmembrane 
domain
SCO5013 secreted protein 0.0479 N/A down Secreted
SCO5073 possible oxidoreductase 4.79E-02 0* down
SCO5074 possible dehydratase N/A 0* down Predicted pI = 8.6; secreted
SCO5079 conserved hypothetical 
protein
N/A 0* down
SCO5123 membrane protein 0.000415 N/A down Predicted pI = 8.2, mwt = 
6622 Da
SCO5124 hypothetical protein 0.00512 N/A down Predicted pI = 7.12, mwt = 
7054 Da
SCO5125 hypothetical protein 0.000788 N/A down None
SCO5166 putative helicase 5.12E-03 N/A up Predicted pI = 9.5
SCO5225 ribonucleotide-diphosphate 
reductase small chain
N/A 0.007* up Predicted 2 transmembrane 
domains
SCO5624 30S ribosomal protein S2 N/A 0.089* down None
SCO5649 unknown N/A 0.1* down None
SCO6197 secreted protein 3.29E-06 0.063 down Secreted
SCO6198 secreted protein 8.09E-03 N/A down Secreted
SCO6346 hypothetical protein 6.08E-03 N/A down None
SCO6362 Probable two-component 
sensor
0.00589 N/A down Predicted 6 transmembrane 
domains; pI = 10.43
SCO6637 hypothetical protein 0.000788 N/A down
SCO6638 hypothetical protein 0.000415 N/A down
SCO6808 possible ArsR-family 
regulator
0.00219 N/A down Predicted mwt = 13271 Da
SCO6958 putative membrane protein 0.036 N/A up Predicted 3 transmembrane 
domains; pI= 8.7; mwt = 
11304 Da
SCO7510 peptidyl-prolyl cis-trans 
isomerase
N/A 0.01* up None
SCO7511 glyceraldehyde 3-phosphate 
dehydrogenase
N/A 0* up
SCO7657 secreted protein 1.76E-05 0.066* down Secreted
1 presented in more detail in Additional File 8.
2 genes in bold were also found to be different in the proteome analysis detailed in Additional File 5. Underlined genes were more 
highly expressed during all stages of growth in M600 relative to the bldA mutant. Q-RT-PCR was performed with the 16 RNA samples 
from replicate 3 time courses, using specific primers and probes covering 50–150 bp, for each of the following genes: SCO4295, 
SCO5013, SCO6808, and SCO7657; five genes up-regulated in the bldA mutant – SCO3088, SCO3285, SCO3286, SCO5166, 
SCO6958; the TTA-containing gene SCO6638; and the ribosomal protein genes SCO4648, SCO4702, SCO4705, SCO4717. See 
Additional File 2 for these results.
3from ScoDB [55]
4 from a Welch t-test applying the Benjamini and Hochberg multiple testing correction
5 average pfp (Probability of False Prediction) values from time-point comparisons outputted from Rank Product Analysis. * denotes 
those genes found differentially expressed at one time point only.
6determined from a visual inspection of expression profiles in Additional File 1
7 pI and Mwt values from ScoDB [55]: transmembrane domain predictions from TmPred [56]
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BMC Genomics 2007, 8:261 http://www.biomedcentral.com/1471-2164/8/261could similarly stimulate ppGpp synthesis. Intracellular
ppGpp concentrations were therefore analysed by HPLC
at four comparable timepoints leading up to transition
phase in cultures of M600 and M600 ΔbldA similar to
those used for the RNA and protein analysis. The levels in
the bldA mutant were consistently two- to six-fold higher
at each timepoint in the mutant than in the parent strain
(Fig. 2B), supporting the idea that the observed large-scale
changes in transition-phase transcription patterns are
related to altered patterns of ppGpp synthesis. GTP levels
were comparable between the two strains.
These results raise the strong possibility that some of the
changes in the mRNA and protein profiles resulting from
the deletion of bldA may be indirect effects of changes in
the level of ppGpp. However, such effects are unlikely to
be the principal reason for the most obvious features of
the mutant phenotype, since the deficiencies in morpho-
logical development and actinorhodin synthesis can be
suppressed by specifically replacing TTA codons in appro-
priate regulatory genes by alternative leucine codons
[13,14].
Among 102 differentially represented protein spots (corresponding 
to 84 genes), the majority are maximally abundant in stationary 
phase in the wild-type
In the global proteomic analysis, about 750 spots were
subjected to fluorescence quantification in each pI range,
i.e. about 1,500 in all. Of these, 336 were identified by
mass spectrometry of tryptic digests (see Additional File 4
for quantitative data for these identified spots). The selec-
tion of spots for characterisation was to some extent
guided by obvious temporal regulation, or changes in
abundance between the two strains. 42 of the 336 spots
were differentially represented between the two strains
according to the Mann-Whitney U-test, and 35 of these
were also among the 95 found to be differentially repre-
sented by a different procedure, employed to compensate
for a limitation of the statistical approach (discussed
below). This second procedure searched for spots whose
normalized volumes were changed two-fold or more
between strains in both biological duplicate growth
curves and in at least two (of the five) corresponding time-
points (see Methods for further details of the analytical
procedures). The two groups of proteins gave a combined
total of 102 differentially represented spots (about 7% of
the c. 1500 quantified spots: see Additional File 5, and Fig.
3). As in the transcriptome analysis, some bldA-influenced
protein spots (25/102) were more abundant in ΔbldA
than the parent strain, one of these (SCO3285, encoding
a large glycine/alanine-rich protein) being detected in
both analyses.
To assess the impact of bldA mutation on proteins
expressed at different growth phases in the parent strain,
the 336 proteins were grouped into one of six temporal
expression pattern classes by applying a set of simple
mathematical rules (see Methods). A summary is shown
in Fig. 3A (see Additional File 6 for detailed lists). We
emphasise that the bias in spot selection means that some
of these classes are over-represented (notably class B,
expression mainly late) or under-represented (such as
class A, expression uniform throughout growth). As indi-
cated in Fig. 3, the great majority of the spots influenced
by bldA showed strong up-regulation in stationary phase
in the wild-type (class B), though four examples were
found of a bldA-influenced spot that was more or less con-
stitutive, echoing the evidence from microarray analysis
that bldA has some effects during exponential phase (class
A). The strong growth-stage-specificity of most proteins
influenced by bldA was consistent with the observation
Aberrant transition phase physiology as a result of bldA muta-tionFigu e 2
Aberrant transition phase physiology as a result of bldA muta-
tion. (A) Patterns of ribosomal protein gene expression in 
M600 and M600 ΔbldA are markedly different at timepoints 3 
and 4. (B) Synthesis of the stringent factor ppGpp is 
increased in transition phase cultures of M600 ΔbldA.
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BMC Genomics 2007, 8:261 http://www.biomedcentral.com/1471-2164/8/261that the bldA-specified tRNA is unusual in being most
abundant in stationary phase, in contrast to most tRNAs,
which are most abundant at high growth rates [15,16].
Most of the differences between protein spot lists from the
two mathematical approaches can be accounted for by the
blindness of the Mann-Whitney U-test to the expression
pattern most common among bldA-influenced spots. Fig-
ure 3C shows that when a protein spot is completely
absent at all timepoints in both growth curves of one
strain, it needs to be present in at least 3 of the 5 time-
points in both curves of the second strain in order to be
called significantly different by that procedure. Thus, the
largest discrepancies between the two procedures are in
expression group B, where protein spots may be detected
only in the last two timepoints, and in the group of 10
proteins not detected at all in M600 (Fig. 3B). In total
these groups account for 48 of the 59 differences between
the two protein lists, and indicate why it was important to
use both differential representation assessment proce-
dures. The reasons for the unexpectedly small overlap
between the differential expression lists obtained by pro-
teome and transcriptome analyses are discussed below.
bldA mutation affects some proteins post-translationally
An unexpected new aspect of the bldA phenotype was the
changes observed in post-translational modification/
processing of 11 proteins (Table 2 and see Additional File
7). Nine of these were detected as pairs of spots with sim-
ilar apparent molecular weights but differing isoelectric
points, and in three of the nine cases one of the two forms
of the protein was completely absent in the bldA mutant
(SCO1916, SCO3073, and SCO3137). The other two of
the 11 proteins were detected as pairs of spots differing in
both molecular weight and isoelectric point (SCO5465,
SCO2271). One of the SCO5465 spots in M600, with an
apparent molecular weight of about 40 kDa, was absent
from the bldA mutant, while the other, corresponding to
the 23 kDa predicted from its amino acid sequence, and
presumably unmodified, was more abundant in the
mutant. Neither of the two SCO2271 spots coincided
Summary of results from analysis of the proteomeFigure 3
Summary of results from analysis of the proteome. The majority of spots that are different in the ΔbldA mutant are most abun-
dant in M600 during the stationary phase. (A) Grouping of identified protein spots according to their abundance profiles in 
M600. (B) Protein spots identified that are considered to be altered in expression in ΔbldA. Figures given are the number of 
spots that reproducibly exhibit a two-fold or higher change in abundance in the ΔbldA mutant strain, followed by a bracketed 
figure indicating the number of these that are also statistically significantly different. (C) Table showing that the statistical 
approach is limited to proteins that are reproducibly more abundant in at least three of the five timepoints.
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BMC Genomics 2007, 8:261 http://www.biomedcentral.com/1471-2164/8/261with the 2D gel location predicted for a 48 kDa protein of
pK 6.8. However, SCO2271 is expected to be processed
and exported from the cell, and the observed position of
the higher molecular weight spot coincides with that pre-
dicted for the secreted protein (pH 5.9, 45 kDa). This form
of the protein, possibly anchored in the cell membrane by
a predicted transmembrane helix at its C-terminus, was
more abundant in the parent strain in the stationary phase
samples while the smaller of the two protein spots was
approximately equally abundant in both strains.
Summary of global effects of bldA mutation
In summary, 147 genes were identified as being affected
by bldA deletion, 63 and 73 uniquely from transcriptom-
ics or proteomics respectively (Table 1 and see Additional
Files 5 and 8). Eleven genes were found in both analyses
(their transcript and protein abundance profiles are com-
pared in Additional File 9). All 147 genes are considered
together in subsequent sections dealing with the effects of
bldA deletion on secondary metabolism and with the
genetic routes by which some genes are affected by the
deletion. We also consider some evidently meaningful
effects of the bldA deletion that were not found by the sta-
tistical analysis.
Mutation of bldA has little effect on primary metabolic 
genes associated with growth, but does affect some 
genes associated with nutritional stress, as well as 
more secondary metabolic genes than previously 
recognised.
Primary metabolism
The growth rate of the bldA mutant in minimal media is as
rapid as that of the wild-type (possibly it is even faster: Fig
1; D. W. Kim and K. J. Lee, personal communication). The
mutant was therefore not expected to show significant
changes in the abundance of mRNAs or proteins involved
in primary metabolism. In general confirmation of this,
the major biosynthetic pathways for amino acids, nucle-
otides and vitamins were apparently unaffected, with the
exceptions of aromatic amino acid biosynthesis
(SCO1496, chorismate synthase; and SCO2115, one of
two aroH-like genes for the first step) and biotin biosyn-
thesis (SCO1244, 1246); and among the central pathways
of primary carbon metabolism (glycolysis, the pentose
phosphate pathway, the citric acid cycle, the glyoxylate
cycle, gluconeogenesis), the only major changes seen
involved increased abundance in the bldA mutant of pro-
tein and mRNA from one of three genes annotated as glyc-
eraldehyde-3-phosphate dehydrogenase (SCO7511,
gap2) (of the two other paralogues, SCO1947 protein was
detected in all samples and SCO7040 was not detected in
any). SCO7511 is orthologous with a gap gene of Strepto-
myces aureofaciens that was reported to be induced at the
time of aerial growth on glucose-free medium [17]. In
addition, a spot comprising a fragment of citrate synthase
(SCO2784) was enhanced in the proteome of the mutant,
though the major citrate synthase spot was unaffected.
However, some effects were seen on more peripheral
aspects of primary and salvage metabolism, such as might
be expected to be active after the main growth phase. The
more basic of two SCO3073 (putative urocanate
hydratase, hutU) spots was absent from the mutant; the
product of a conserved hypothetical gene apparently
translationally coupled to the downstream rocD (orni-
thine aminotransferase)-like gene was less abundant in
the mutant; and a putative uracil phosphoribosyltrans-
ferase (SCO4041, nucleotide salvage) was likewise less
Table 2: Changes observed in the post-translational modification of proteins as a result of bldA mutation
Gene Function1 Alteration in protein abundance2 observed for:
Spot 1 Spot 2
A) Spots differ in isoelectric point (pI): spot 1 has more acidic pI than spot 2
SCO1246 BioD (dethiobiotin synthetase) >2-fold up in ΔbldA >2-fold down in ΔbldA
SCO1916 Putative transferase Absent in ΔbldA No change
SCO2390 FabF (3-oxoacyl- [ACP] synthase II No change >2-fold down in ΔbldA
SCO2618 ClpP2 (Clp-protease subunit 2) >2-fold up in ΔbldA >2-fold down in ΔbldA
SCO3073 HutU (urocanate hydratase) No change Absent in ΔbldA
SCO3137 GalE1 (UDP-glucose 4-epimerase) Absent in ΔbldA No change
SCO3409 Ppa (inorganic pyrophosphatase) >2-fold up in ΔbldA >2-fold down in ΔbldA
SCO4164 CysA (thiosulphate supfurtransferase) >2-fold up in ΔbldA >2-fold down in ΔbldA
SCO7400 ABC transport protein >2-fold down in ΔbldA No change
B) Spots differ in Mwt (and pI): spot 1 has higher Mwt than spot 2
SCO2271 Putative membrane protein >2-fold down in ΔbldA No change
SCO5465 Conserved hypothetical protein Absent in ΔbldA >2-fold up in ΔbldA
1from ScoDB [55]
2protein abundance profiles for all 22 protein spots are detailed in Additional File 7.Page 8 of 22
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both a basic and an acidic form of SCO4164, a homo-
logue of thiosulphate sulphurtransferase (cysA,
SCO3920), were seen in the mutant.
Interestingly, multiple protein forms were associated with
ten of the 17 bldA-influenced protein spots potentially
associated with primary/intermediary metabolic proc-
esses (central carbon metabolism, amino acid biosynthe-
sis etc), suggesting that the majority of these effects may
be indirect subtle changes in post-translational modifica-
tions (see Additional File 5).
Secondary metabolism
Streptomycetes are very important producers of antibiot-
ics and other valuable secondary metabolites. Bentley et
al. [4] identified 21 genes or gene clusters in the genome
sequence of S. coelicolor that are likely to determine sec-
ondary metabolite production. In our proteomic analysis,
the abundance of gene products from seven of these was
found to be affected by bldA, one of them, a Type III
polyketide synthase (SCO7221), being more abundant in
the mutant (Fig. 4 and see Additional File 10). Previously,
only two of these gene sets (act and red) had been found
to be influenced by bldA. In general, proteomic analysis
here and in previous work [18] failed to detect some of the
proteins specified by each cluster. In most cases this
reflected the properties of the proteins themselves (size,
charge, cellular location). For reasons discussed below,
only two of the secondary metabolism gene sets (for Act
and coelichelin) were among those identified as being
affected by bldA in the transcriptome analysis (see Table
1).
act gene cluster (SCO5070-5092)
The acetate-derived blue aromatic polyketide, actinorho-
din, whose production is encoded by the extensively stud-
ied act genes, is absent from bldA mutants. Each of the 5
act biosynthetic transcription units was represented by at
least one spot in the proteomic analysis, and each showed
strong dependence on growth phase and on bldA (see
Additional File 10). Three act genes, SCO5073, SCO5074
and SCO5079, were also identified from the transcrip-
tome analysis. Putting these data together with previous
less extensive results, it appears that every act biosynthetic
operon is likely to be regulated by actII-ORF4, the path-
way-specific regulatory gene containing the TTA codon
previously shown to mediate bldA-dependence of actinor-
hodin production [14]. Most act genes were not identified
as significantly differentially expressed by transcriptome
analysis, although there is compelling evidence from pre-
vious studies that they are very markedly bldA-dependent
[14]. Examination of the microarray data revealed exces-
sive variance within the data for these genes (itself proba-
bly a consequence of noticeable variation in the timing
and onset of pigment development between replicate
experiments). This may be why they failed to meet the
stringent statistical criteria employed: relaxing the criteria
yielded more act genes (data not shown; with Rank Prod-
uct analysis the additional act genes had associated p-val-
ues of less than 0.05 but the pfp values were above 0.1).
red gene cluster (SCO5877-5898)
The red prodiginine pigments determined by the red gene
cluster are absent from bldA mutants except under certain
conditions (e.g. low phosphate [19]). Only one Red bio-
synthetic protein, the methyl transferase RedI, was
detected in this study. It appeared in the later time points,
when redI transcripts also became more abundant. RedI
abundance was strongly dependent on bldA, probably
because of a TTA codon in redZ [19], which encodes an
atypical response regulator believed to activate a second
regulatory gene, redD, that in turn activates at least some
of the red biosynthetic genes [20]. Thus, the bldA-depend-
ence of RedI may reflect either a direct dependence of redI
on RedZ, or an indirect effect via RedD. As with the act
genes (see above), further red genes were detected as dif-
Mutation in bldA has wide-ranging effects on secondary me b lismFigure 4
Mutation in bldA has wide-ranging effects on secondary 
metabolism. The figure presents a stylised illustration of the 
8.7 Mbp S. coelicolor linear chromosome, with the 21 genes or 
gene clusters that determine secondary metabolite produc-
tion marked with arrows, and those that are altered in 
expression in M600 ΔbldA asterisked. The thick orange line 
represents the central core of the chromosome rich in 
essential functions and containing the origin of replication 
(ori).
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were relaxed.
cda gene cluster (SCO3210-3249)
S. coelicolor produces a lipopeptide antibiotic CDA which
is chemically similar to daptomycin, a drug recently
approved for the treatment of certain MRSA infections
[21]. The oxygenase encoded by SCO3236, the only pro-
tein detected from the CDA cluster, dramatically increased
in abundance in the parental strain during transition
phase before falling back during late stationary phase.
Levels of this protein were reduced in the bldA mutant.
Deoxysugar/glycosyltransferase cluster (SCO0381-0401)
These 21 genes are arranged in what could be a single
operon, with the largest intergenic region being 102 bp
between SCO0386-0387. They include two TTA-contain-
ing genes (SCO0383 and 0399), neither of regulatory
character, and neither being represented in the proteome.
Proteomics data were collected for five proteins from this
cluster, and four were found to be reduced in abundance
by two-fold or more in the bldA mutant. The complete
absence from the bldA mutant of gene products from the
last two genes in the cluster, SCO0400 and 0401, suggests
that the TTA codons in upstream genes could exert polar-
ity effects. The reduced abundance of mRNA for the first
two genes in the cluster, which are upstream of the TTA
codons, although not statistically significant, perhaps sug-
gests that polarity effects on protein synthesis may result
in destabilisation of the whole message (see also below).
Type III PKS (SCO7221)
The Type III polyketide synthase specified by SCO7221,
which has very recently been shown to be responsible for
the production of a germination inhibitor, germicidin
[22], increased slightly in abundance during growth of the
parent strain M600, peaking in the last stationary phase
sample, but was 5- to 10-fold overproduced in the bldA
mutant at all time-points (see Additional File 10). QRT-
PCR confirmed that the transcript was also more abun-
dant in the mutant strain, especially in the later time-
points (data not shown).
Coelichelin biosynthetic cluster (SCO0489-0499)
The non-ribosomal peptide synthetase encoded by this
cluster produces an iron-chelating metabolite, coelichelin
[23]. Although there are no TTA-containing genes in or
near the cluster, the products of SCO0498 and 0499 were
less abundant in the bldA mutant, while the products of
SCO0490 and 0494 were unaffected. The SCO0499 gene
was also identified as being significantly differentially
expressed from the transcriptome data. Unusually among
the secondary metabolism-related proteins detected in
this work, these gene products were readily detected
before the onset of stationary phase (see Additional File
10). The presence of regulatory DNA sequence motifs sim-
ilar to iron-dependent repressor binding sites upstream of
several genes in this cluster suggests responsiveness to the
intracellular iron concentration [24]. It is not known
whether the effects of bldA are independent of iron-
responsiveness.
Desferrioxamines biosynthetic cluster (SCO2782-2785)
Like the coelichelin biosynthetic cluster above, the desfer-
rioxamines cluster encodes production of an iron
siderophore [25], and possesses an iron-dependent
repressor motif upstream of the first gene in the cluster
(SCO2782). Two proteins from this cluster were detected
in the proteomics data from this experiment: SCO2784
protein was more abundant in the bldA mutant during
some of the early timepoints when compared to the
parental strain, and SCO2785 shows a slightly altered pat-
tern of expression in the mutant strain.
Roles of regulatory and TTA-containing genes in the 
changed patterns of gene expression in the bldA 
mutant.
Of the 147 TTA-containing genes in the annotated
genome of S. coelicolor, 19 are predicted to encode regula-
tory proteins [26]. None of these 19 proteins was detected
by proteomics, presumably because of low abundance in
the growth conditions studied. However, reduced expres-
sion of genes known to be activated by TTA-containing
regulatory genes provided indirect evidence for the
absence from the bldA mutant of the regulatory proteins
encoded by adpA (which controls SCO0762 [8]), actII-
ORF4 (which controls the act cluster genes [27,28]), redZ
(which controls the red cluster genes via redD [20]) and
SCO4263 (which controls SCO4251-4253: see below). In
addition, regulatory proteins encoded by three TTA-free
genes were reduced in abundance in the bldA mutant, per-
haps accounting for at least some of the changes in gene
expression in the mutant. One of the three is an ArsR-fam-
ily transcriptional regulator (SCO6808), so it was interest-
ing that a motif reminiscent of the ArsR-binding site
determined in E. coli [29] (see Additional File 11, motif 3)
precedes a group of six differentially expressed genes.
Another of the three is a nickel-responsive Fur-like repres-
sor of a putative nickel transport operon (SCO4180 [30]).
A SCO4180 deletion mutant exhibited a higher intracellu-
lar nickel concentration than the parent [30], so bldA may
be similarly affected. The third (SCO4677) showed
homology to sensory histidine protein kinases. SCO6362,
encoding another such kinase, was also significantly
altered in its pattern of transcription.
One of many likely operons affected by bldA is the target of a 
regulator encoded by a nearby TTA-containing gene
Of the 147 genes identified as being bldA-influenced in
Table 1 or Additional File 5, 87 are probably co-tran-Page 10 of 22
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operons. Sixteen of these operons have more than one
member listed in Table 1 or Additional File 5 (equivalent
to 42 genes), reinforcing their classification as bldA-
dependent. Apart from those involved in secondary
metabolism (see above), the others include a cluster of
function-unknown genes whose expression was particu-
larly strongly dependent on bldA at the mRNA (SCO4246,
SCO4252-3, SCO4256 and SCO4262; Fig. 5A) and pro-
tein levels (SCO4251-3; Fig.5B) [9]. A search of the
genome revealed a nearby TTA-containing gene,
SCO4263, encoding a LuxR-family regulator. The effect of
deleting SCO4263 on expression of the SCO4251-4253
operon was therefore analysed. S1 nuclease protection
experiments indicated that transcription of SCO4253, the
first gene in the putative SCO4251-4253 operon (Fig. 5C),
starts 32 bp upstream of the translational start site, and is
completely dependent on SCO4263 (Fig. 5D, E). As a con-
trol, transcription of another strongly bldA-dependent
gene, SCO0762 [8], was unaffected in the SCO4263
mutant. Proteomic analysis also demonstrated that the
SCO4251-4253 proteins, readily detected in the parent
strain, were absent from the SCO4263 mutant (data not
shown), confirming the bldA-dependence of these three
genes via the TTA-containing regulator. There was no
Expression of a cluster of function-unknown genes is dependent on bldAFigure 5
Expression of a cluster of function-unknown genes is dependent on bldA. (A) Transcriptome and (B) proteome data showing 
the bldA-dependence of expression of the genes of unknown function SCO4251-4253, SCO4246, SCO4256 and SCO4262. (C) 
Genetic organisation of the SCO4251-4253 locus. (D) Transcription of the SCO4253 gene during growth of strains M600 and 
M600 Δ SCO4263 in SMM. RNA was isolated during the mid-exponential (E) and early stationary (S) phases of growth and sub-
jected to S1 nuclease protection analysis using uniquely end-labelled PCR-generated probes. Transcription of the SCO0762 
gene was analysed as an internal control for RNA quality and loading. (E) Sequence upstream of the SCO4253 gene indicating 
the location of the single transcription start site (bent arrow), upstream of the ATG translation start codon (block arrow).
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of SCO4263.
Apparent destabilisation of UUA-containing polycistronic mRNA by 
bldA deletion
The transcript of SCO6638, a TTA-containing gene of
unknown function, was less abundant, and its gene prod-
uct – the only one from a TTA-containing gene to be
detected in the proteome analysis – completely absent, in
the bldA mutant. The stop codon of SCO6638 overlaps the
start site for the downstream SCO6637 gene, whose RNA
and protein products were also less abundant in the bldA
mutant, indicating that the two genes are cotranscribed
and possibly translationally coupled. Possibly, a polarity
effect on protein synthesis resulting from stalling of trans-
lation at the SCO6638 UUA codon upstream accounts for
reduced SCO6637 expression, and the consequent uncou-
pling of transcription and translation may further result in
exposure of the mRNA to RNase action, in turn reducing
the half-life and overall abundance of mRNA correspond-
ing to both genes. Such an explanation may also account
for the similar situation described above for the deox-
ysugar cluster (SCO0381-0401).
Another group of linked genes, SCO0991-0995, most of
which encode integral membrane proteins, was preferen-
tially transcribed late in the wild-type, and transcription
of SCO0991 (protein kinase), SCO0994 (function
unknown) and SCO0995 (methyl transferase) was
reduced in the bldA mutant. SCO0992, the TTA-contain-
ing gene encoding a putative cysteine synthase, and
SCO0993 were not identified as being significantly
affected by bldA mutation, presumably failing to meet the
statistical criteria (though there are alternative explana-
tions, including differences in half-lives of component
transcripts or the presence of internal independent pro-
Table 3: bldA-dependent genes for which some direct link to bldA can be proposed
Gene1 Gene product2 Reference
A: Containing a TTA codon
SCO4262 Hypothetical protein [55]
SCO6638 Hypothetical protein [55]
B: Regulated by a TTA-containing gene
By adpA
SCO0762 Protease inhibitor [55]
By SCO4263
SCO4246 Hypothetical protein [55]
SCO4251 Putative secreted protein This study
SCO4252 Hypothetical protein This study
SCO4253 Conserved hypothetical protein This study
By act II-ORF4
SCO5071 Hydroxylacyl-CoA dehydrogenase, ActVI-ORFA [14]
SCO5073 Putative oxidoreductase, ActVI-ORF2 [14]
SCO5074 Putative dehydratase, ActVI-ORF3 [14]
SCO5075 Putative oxidoreductase, ActVI-ORF4 [14]
SCO5078 Hypothetical protein [14]
SCO5079 Conserved hypothetical protein [14]
SCO5086 Ketoacyl reductase, ActIII [14]
SCO5088 Polyketide beta-ketoacyl synthase, ActI-ORF2 [14]
SCO5090 Actinorhodin polyketide cyclase/dehdratase, ActVII [14]
By redZ
SCO5895 Putative methyltransferase, RedI [20]
C: In a putative operon with a TTA-containing gene
SCO0392 Putative methyltransferase [31]
SCO0395 Putative epimerase/dehydratase [31]
SCO0400 Putative epimerase [31]
SCO0401 Putative aminotransferase [31]
SCO0991 Conserved hypothetical protein [31]
SCO0994 Integral membrane protein [31]
SCO0995 Probable methyltransferase [31]
SCO6637 Hypothetical protein [31]
1the combined list of 147 bldA-affected genes as determined by transcriptomics and/or proteomics was considered
2from SCODB [55]Page 12 of 22
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ces: e.g. Laing et al. [32]). The half-life of the UUA-
containing putative polycistronic SCO0991-0995 mRNA
may therefore also be affected by bldA-dependent uncou-
pling of transcription and translation. We note that the
gene next to, and diverging from, the SCO0991-0995 clus-
ter, SCO0990, and also encoding a membrane protein,
was also bldA-dependent.
Discussion
Few of the genes found to be affected by bldA contain TTA 
codons
Some 147 genes were found by RNA and/or proteome
analysis to be affected by bldA. Further differences are
likely to be found when the strains are growing on the sur-
face of agar, conditions in which the mutant forms no
obvious aerial mycelium or spores. Some genes (31/147)
showed increased expression in the bldA mutant. Of the
47 whose protein products were found to be less abun-
dant in the mutant, only one (SCO6638) has a TTA
codon. [Only one other protein among those seen on gels
was specified by a gene (SCO6717) annotated as TTA-con-
taining, and closer examination of the SCO6717 sequence
indicates that the TTA codon falls upstream of a likely
translation start codon.] The gels examined contained
about 1500 different protein spots. Based on a reported
average of 1.2 spots per gene [18], these correspond to
about 1250 genes, i.e. about 16% of the genome. The
products of the TTA-containing genes in the S. coelicolor
genome (147 in the analysis of Li et al. [26]) are therefore
strikingly under-represented in our analysis. Thus, the
growth conditions used here (submerged growth in
casaminoacids-supplemented minimal medium) did not
favour the expression of most of these genes. This would
be consistent with the idea that many TTA-containing
genes are adapted for expression either during surface
growth and differentiation, or in specialised ecological
niches or physiological responses. A similar conclusion
was reached by Li et al. [26], in a study in which mutations
in 21 TTA-containing genes of S. coelicolor were found to
cause no obvious phenotypic changes. Since nearly all of
the genes that seemed to be influenced by bldA in our
analysis lack a TTA, these effects must have been indirect.
Three indirect routes probably account for most of the
effects (Table 3). First, some of the bldA-influenced genes
are regulated by TTA-containing genes, most of which are
expressed at levels too low to make them amenable to the
analytical procedures employed. We estimate that
dependence on such weakly-expressed TTA-containing
genes accounts for the bldA-dependence of at least 15
genes found in the transcriptome and proteome analyses.
The upstream sequences of the genes with differentially
expressed transcripts were analysed to identify over-repre-
sented DNA motifs that may be indicative of co-regula-
tion of genes by the same regulatory protein, and the ten
statistically most significant motifs are shown in Addi-
tional File 11. None resemble binding motifs reported or
proposed for the S. coelicolor regulators encoded by TTA-
containing genes i.e. AdpA [8], ActII-ORF4 [33], RedZ
(White and Bibb, personal communication), or previ-
ously reported consensus promoter sequences in S. coeli-
color. Secondly, eight of the genes affected are probably co-
transcribed with TTA-containing genes, and the resulting
UUA-containing mRNAs may have a reduced half-life
under conditions in which the UUA codon is not readily
translated. Thirdly, bldA deletion changes the profile of
ppGpp abundance and eliminates a transient upshift in
transcription of ribosomal protein genes at the transition
phase that precedes entry into stationary phase (see Fig.
2A). This extraordinary effect may arise through a trigger-
ing of the stringent response, because of ribosomes
encountering untranslatable UUA codons in a small pro-
portion of mRNAs. It is likely that the changed ppGpp lev-
els will affect the expression of some genes even before
transition phase, and that the disturbance of transition
phase gene expression will have knock-on effects on gene
expression during stationary phase, the stage at which
most of the known phenotypic consequences of bldA
mutation are manifested.
Significant global correlation between protein and transcript abundanceFigure 6
Significant global correlation between protein and transcript 
abundance. (A) Table listing correlation coefficients and sig-
nificance P-values characterising the relationship between 
protein and transcript abundance in liquid-grown cultures of 
M600 and M600 ΔbldA at different stages of growth. (B) 
Graph illustrating the positive correlation between protein 
and transcript abundance in strain M600 at the earliest time-
point.
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transcriptomic analysis ("dualomics")
For a number of reasons, discussed at various points in the
preceding text, we did not expect to find simple global
correlations between transcript and protein levels, partic-
ularly in view of the fact that no system of statistical anal-
ysis is well-suited to integration of the kinds of data given
here. Nevertheless, using the Spearman Rank correlation
as detailed in the Methods, there was a weak but signifi-
cant global correlation at the 5% level between the pro-
teome and transcriptome values at each time-point, with
correlation coefficients ranging from 0.15 to 0.34 for
wild-type timepoints 8 and 1, respectively, and 0.13 to
0.34 for the corresponding times in ΔbldA (Fig. 6). Only
11 genes were positively correlated across both strains at
the 0.05 probability level, while five genes notably even
showed significant negative correlations between tran-
script and protein abundance (Table 4). Three of the latter
genes encode highly important enzymes of primary
metabolism (SCO1947, glyceraldehyde-3-phosphate
dehydrogenase; SCO2198, glutamine synthetase; and
SCO2736, citrate synthase), and in each case the anomaly
could be ascribed to changes in the modification/process-
ing state of the protein. A similar explanation has not
Table 4: Genes that have a high confidence in congruence between protein and transcript profile during growth
Gene/spot Confidence ((1-p) × 100) Spearman rank correlation Annotated gene function
Positive correlation in set A
SCO0379:123 100 1 catalase KatA
SCO1651 100 1 conserved hypothetical protein
SCO1776 100 1 putative CTP synthetase PyrG
SCO2554 100 1 DnaJ
SCO7510 100 1 peptidyl-prolyl cis-trans isomerase CypH
Positive correlation in set B
SCO1212 100 1 putative ligase
SCO2115 100 1 putative 2-dehydro-3-deoxyphosphoheptonate aldolase AroH
SCO2539 100 1 Era-like GTP-binding protein
SCO3801 100 1 putative aminopeptidase
SCO3907 100 1 single strand DNA-binding protein ssb
SCO4809 100 1 succinyl CoA synthetase alpha chain SucD
SCO4813 97.7 0.87 phosphoribosylglycinamide formyltransferase PurN
SCO4824 98.4 0.89 bifunctional protein (methylenetetrahydrofolate dehydrogenase and 
methenyltetrahydrofolate cyclohydrolase FolD
SCO4921 100 1 putative acyl-CoA carboxylase complex A subunit AccA2
SCO5745 100 1 conserved hypothetical protein
Positive correlation in set C
SCO0379:123 97 0.85 catalase KatA
SCO1244 98 0.88 Biotin synthase BioB
SCO1489 98.4 0.89 DNA-binding protein BldD
SCO1523 98.4 0.92 conserved hypothetical protein
SCO1651 98.4 0.89 conserved hypothetical protein
SCO1776 99.8 0.96 putative CTP synthetase PyrG
SCO2949 98 0.88 UDP-N-acetylglucosamine transferase MurA
SCO3122 98.4 0.9 putative nucleotidyltransferase
SCO4550 98.4 0.9 conserved hypothetical protein
SCO4813 97.7 0.87 phosphoribosylglycinamide formyltransferase PurN
SCO4824 98.4 0.89 bifunctional protein (methylenetetrahydrofolate dehydrogenase and 
methenyltetrahydrofolate cyclohydrolase FolD
SCO5113 98.4 0.9 BldKB, putative ABC transport system lipoprotein,
Negative correlation (all in set C)
SCO1947:683 98.4 -0.86 glyceraldehyde-3-phosphate dehydrogenase Gap1
SCO2198:235 97.7 -0.87 glutamine synthetase I GlnA
SCO2198:746 98.8 -0.92 glutamine synthetase I GlnA
SCO2634 97 -0.85 conserved hypothetical protein
SCO2736:472 95.1 -0.83 Citrate synthase CitA
SCO5466 97.8 -0.87 putative hydrolase
Congruence across time was calculated by Spearman Rank Correlation given different data sets where set A represents 5 time points in M600, B 
represents 5 time points in ΔbldA and C represents 10 time points spanning both M600 and ΔbldA (the 5 time points are 1, 2, 4, 6 and 8 in Fig. 1).Page 14 of 22
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SCO5466, neither of known function).
Comparing Table 1 and Additional File 5, only eleven
bldA-influenced genes were found by both approaches (six
when considering only the statistically significant pro-
teome differences). However, at least 53 of the 74 signifi-
cantly differentially transcribed genes encode proteins
that are predicted to be undetected in the 2D gel proteom-
ics approach employed, because of their physical proper-
ties (basic pI, low molecular weight (<13 KDa), multiple
transmembrane domains or putative secretion: (see Table
1)). Indeed, four of the genes in Table 1 that encode puta-
tively secreted protein products (SCO0297, 0762, 1968
and 6198) and are down-regulated in bldA, were reported
to be less abundant in the mutant extracellular proteome
[8]. Taking this into account, there were ten discrepancies
involving failure of the proteome analysis to find genes
picked out in the transcriptome study, and this may be
associated with limitations of the proteomics approach
for detecting proteins of low abundance. In addition, the
higher number of replicates and sampling points in the
transcriptomics study will have increased the power of
this analysis for determining statistically significant
changes. Some changes in the proteome were not picked
up by transcriptome analysis. Many of these may reflect
either post-translational processes of potential physiolog-
ical significance (e.g. proteins in Table 2), or differing sta-
bilities of the mRNA and corresponding protein products
of gene expression. Thus, there are real benefits in using a
combination of proteome and transcriptome analyses to
assess global gene expression, where limitations in one
technique tend to be compensated by strengths of the
other. Because of its sensitivity and genuinely global
nature, the transcriptome approach captures data on
lowly expressed genes, and on secreted, membrane or
high molecular weight gene products, which are all poorly
represented in whole-cell proteomics data. Proteomics on
the other hand informs on the abundance of the end-
product of gene expression, encompassing the effects of
both post-transcriptional and post-translational regula-
tory mechanisms that cannot be glimpsed through tran-
scriptomics.
Conclusion
The role and evolution of a bldA-based checkpoint for 
Streptomyces differentiation
Taking into account the sum total of information now
available about the effects of bldA mutations, and the
occurrence and nature of TTA-containing genes in strepto-
mycetes, we suggest the following bldA-centred model of
Streptomyces physiology.
Nutrient-limited conditions in most bacteria, including
streptomycetes, are signalled through a mechanism
involving ppGpp that generally results in decreased pro-
duction of the machinery for macromolecular synthesis,
including tRNAs. In the case of streptomycetes, such con-
ditions may apply either when the environment changes,
or in centrally located parts of the colony in which nutri-
ent demands have come to outstrip the rate at which exter-
nal supplies can diffuse in. It is in the latter parts of the
colony that morphological and physiological differentia-
tion take place. The transcription of the bldA-specified
pro-tRNA and its processing to a mature form are
increased in these conditions, as if bldA responds to nutri-
ent limitation in the opposite way from other transla-
tional components. Indeed, nutritional shiftdown-
induced increases in ppGpp concentration that strongly
inhibited transcription of the rrnD geneset for 16S rRNA
did not inhibit bldA transcription and processing [34].
A relative increase in the level of bldA tRNA provides an
intracellular environment suitable for the translation of
UUA-containing mRNA. In view of our evidence suggest-
ing that such mRNAs have reduced abundance when the
translation of their UUA codons is restricted, their free
translation would increase the abundance of the mes-
sages, potentially further increasing the levels of the pro-
tein products. This enhancement may apply to individual
structural genes or whole operons (such as the deoxysugar
cluster SCO0381-0401), causing rapid changes in the
activity of the corresponding biochemical activities and
pathways. Such pathways nearly all show some degree of
species-specificity, and many of them probably confer
adaptive benefits in very particular environmental circum-
stances [26]. The enhancement should also apply to the
expression of TTA-containing regulatory genes. Some of
these activate pathway gene sets for antibiotic biosynthe-
sis, and one, adpA, activates some critical aspects of mor-
phological differentiation, at least partially by influencing
an extracellular protease cascade [8]. Others activate
other, often still uncharacterised, gene sets (such as the
SCO4251-4253 operon). We presume that many of the
processes showing some dependence on bldA are also sub-
ject to other regulatory influences, and that the role of
bldA is to provide one of possibly several checkpoints that
must be achieved before commitment to particular physi-
ological activities, such as the onset of secondary metabo-
lism or the activation of substrate mycelium autolysis that
is associated with reproductive aerial growth.
If exposure of UUA-containing mRNA to ribosomes lim-
ited for bldA tRNA elicits ppGpp synthesis as our results
suggest, this could reduce the efficiency of transcription of
any genes adapted for expression in conditions favouring
very rapid growth. Many bacteriophage genes have such
adaptations. It could be imagined that the presence of
UUA codons in highly expressed genes of Streptomyces
phages would reduce the effective expression levels ofPage 15 of 22
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evolution of the bldA checkpoint.
Methods
Strains, growth conditions and sampling
S. coelicolor M600 is a prototrophic, plasmid-free strain of
S. coelicolor A3(2) [6]. In the M600 ΔbldA strain, kindly
provided by M. Tao, bldA is completely replaced by an
apramycin resistance cassette. Strains were cultivated with
vigorous agitation at 30°C in minimal medium supple-
mented with 0.2 % casamino acids (SMM) as previously
described [35]. In summary, spores (about 1010 colony-
forming units ml-1) were pre-germinated in 2 × YT
medium [35] for 7 h at 30°C. Germlings were harvested
by centrifugation (5 min at 4000 × g), resuspended in
SMM, and briefly sonicated to disperse any aggregates,
before inoculation into 50 ml of SMM in 250 ml silicon-
ised flasks containing coiled stainless steel springs. Each
flask received the equivalent of 5 × 107 colony-forming
units. Growth curves for producing RNA and protein
extracts to compare M600 and M600 ΔbldA strains were
performed in triplicate, with 35-ml samples being taken
from cultures of each strain at eight culture ages encom-
passing the exponential, transition and stationary phases
(Fig. 1). Typically, 10 ml of each sample was used for RNA
extraction and 25 ml for proteomic analysis. All samples
from all three time-series were subjected to transcriptome
analysis, while for logistical reasons only samples 1, 2, 4,
6 and 8 from two of the time-series were analysed using
proteomics.
Transcriptomics Methods
i) Genomic DNA and RNA extraction
M145 genomic DNA was prepared by the 'Kirby mix'
method described in Kieser et al. [35], except that sarkosyl
replaced TPNS as the detergent. To retain RNA content
and integrity, the mycelium from each 10 ml culture sam-
ple was treated with RNA Protect Bacteria Reagent (Qia-
gen), following the manufacturers' recommendations,
and then stored at -20°C. The procedure used for RNA
extraction was as described at [36] employing RNeasy
purification columns from Qiagen. The RNA was eluted in
a final volume of 250 μl, assessed for structural integrity
using a Bioanalyser system (Agilent Technologies), and
quantified spectrophotometrically using a NanoDrop
ND-1000 instrument (Labtech). The A260/A280 absorption
ratios of the extracted RNA were between 1.8 and 2.
ii) Nucleic acid labelling and microarray hybridization
The procedures for genomic DNA labelling and array
hybridizations were as described at [36]. Briefly, for the
cDNA synthesis and labelling, 15 μg of total RNA was
added to a reaction mixture containing random hexamer
primers (Invitrogen), Superscript II Reverse Transcriptase
(Invitrogen) and Cy3-dCTP (GE Healthcare), and the mix-
ture was incubated at 42°C for 2–4 h. For the labelling of
genomic DNA, ca. 3 μg DNA was labelled in a 50 μl reac-
tion volume with Klenow enzyme and Cy5-dCTP. The
incorporated Cy-dye-dCTP was quantified using a Nano-
drop ND-1000 spectrophotometer. A volume equivalent
to 45 pmol of Cy3-dCTP-labelled cDNA was pooled with
20 pmol of Cy5-dCTP-labelled genomic DNA, dried in a
vacuum centrifuge and resuspended in 45 μl of Pronto!
Universal Hybridisation Solution for long oligos and
cDNA (Corning). For the array hybridisations of biologi-
cal replicates 1 and 2, a salt-based hybridisation solution
was used instead of a formamide-based solution [37].
The microarrays were coated glass slides (Corning GAPS II
for replicates 1 and 2 and Corning UltraGAPS for replicate
3) spotted with PCR amplicons covering ca. 92% of S. coe-
licolor ORFs. The array design and layouts used are
described at [36]. Different array layout and print runs
were used in this work: for the biological replicates 1 and
2 the arrays contained one probe spot for each gene (array
batches Sc9 and Sc10) while the arrays for the third bio-
logical replicate contained duplicate probe spots (batch
Scp28). Microarrays were scanned using an Affymetrix
428 dual laser scanner. The microarray spots were ana-
lysed and quantified using BlueFuse software (Version
3.1; BlueGnome Ltd, Cambridge), which uses statistical
parametrical models for accurate quantification of the
spot signal and background noise.
Proteomics Methods
i) Preparation of protein extracts from cultures
Mycelium was harvested from 25ml samples of cultures
by centrifugation (30 sec, 4000 × g, room temperature)
and immediately frozen in liquid nitrogen, with a transfer
time from culture flask to frozen sample of 1.5 minutes.
Mycelial pellets were stored at -80°C until use. Protein
extracts, prepared as in Hesketh et al. [18], dissolved in
denaturing isoelectric focusing buffer UTCHAPS (7 M
urea, 2 M thiourea, 4% (w/v) CHAPS, 50 mM DTT, 4 mM
Pefabloc SC protease inhibitor, and 40 mM tris pH9.0),
were stored frozen in aliquots at -80°C.
ii) 2D gel separation of proteins, spot quantification and spot 
identification
Protein extracts were subjected to 2D gel electrophoresis
over the pH4.5-5.5 or pH5.5-6.7 isoelectric point ranges
as detailed in Hesketh et al. [18]. For quantitative analysis
of protein abundance profiles, gels were stained with
Sypro Ruby (Bio Rad) according to the manufacturer's
instructions, and scanned using the Perkin-Elmer ProX-
PRESS proteomic imaging system using excitation and
emission wavelengths of 480 nm and 630 nm, respec-
tively. To produce a quantitative analysis of protein abun-
dance profiles, gel images were analysed using PHORETIX
2D version 5.1 (NonLinear Dynamics): spot detection wasPage 16 of 22
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ard' and then manually edited; background subtraction
was performed automatically using the 'Mode of Non-
Spot' setting; and images were then normalised to the
total spot volume for each gel for quantification. Spot fil-
tering was not used, although all spots were manually
edited. Histograms of normalised spot volumes display-
ing changes in spot abundance during growth and
between M600 and the ΔbldA mutant were generated
within the software. Protein spots of interest were excised
from Sypro Ruby-stained gels using the Investigator
ProPic robot from Genomic Solutions, and identified by
tryptic digestion and MALDI-ToF mass spectrometry as
previously described [18]. Identification of proteins from
peptide mass fingerprint data was performed using the
MatrixScience 'Mascot' search engine [38], and was based
on their 'Probability Based MOWSE Score' algorithm. A
MOWSE score of 60 or higher is significant at the 5% level
or better, and proteins in this work typically gave scores >
80 (frequently considerably higher). In addition, no iden-
tification was accepted unless at least 5 peptides represent-
ing at least 20% of the protein sequence were detected in
the MALDI-ToF peptide mass fingerprint. Spots selected
for identification included not only those showing signif-
icant differences between strains (using the non-statistical
approach outlined below), but also some exhibiting only
growth-phase dependent changes in abundance, and a
smaller number of landmark spots that were neither
growth-phase nor strain dependent.
Preprocessing of -omics data
Microarray data
For normalization methods the statistical computing
environment R (Version 2.1.1) [39] and the package
Limma [40] were used. Within-array global median nor-
malisation of log2 cDNA/gDNA ratios was applied to the
data from each array in the analysis. Control and flagged
spots were ignored. The log2 ratios were then scaled to
have the same median-absolute-deviation (MAD) across
arrays [40,41] of the same replicate series (I, II and III).
Only un-flagged data (6,457 genes) were used in differen-
tial expression analyses and in the averaging of replicate
data for the transcriptome-proteome correlation analysis.
Proteomics data
The proteomics data were analysed using both statistical
and mathematical approaches. For the mathematical
methods, normalized spot volumes as generated within
the Phoretix 2D software (see above) were used without
further processing. For all statistical analyses, these nor-
malized spot volume measurements were transformed to
the log2 scale, with an arbitrary value of 1 being assigned
prior to transformation to protein spots too low in abun-
dance to be detected.
Public availability of -omics data
The transcriptome data have been deposited in the
MIAME-compliant ArrayExpress database with accession
number E-MAXD-27 [42]. Proteome data are listed in
Additional File 4 as an Excel file of normalised spot vol-
umes for all 336 identified spots.
Data analysis
Transcriptomics: genes expressed differentially between strains
The choice of analytical method when compiling a list of
differentially expressed genes between conditions is
dependent on numerous factors [43]. For the transcrip-
tomic data two independent methods were used: Welch t-
test and Rank Product analysis [44]. Whilst t-test based
approaches are commonly used for analysing microarray
data it is apparent that when there is large variance
between biological replicates (as is the case with Strepto-
myces cultures) and/or crucial single time-point changes
(in this analysis), the t-test has shortcomings [[43,44], this
study]. Consequently, the more 'biology friendly' tech-
nique of Rank Products [44] was also used. Comparison
of the gene lists produced when applying the respective
thresholds (Welch t-test p-value < 0.05, Rank Product pfp
value < 0.1) revealed little overlap between them. Hence,
to avoid biasing any interpretation of the results the lists
generated by the two techniques were combined.
Welch t-test
The preprocessed data were imported into Genespring 7.2
(Agilent technologies) for further analysis and genes
deemed to be 'non-changing' were filtered out from the
un-flagged transcriptome data by removing those with
log2 expression values between -0.667 and 0.667 in all 16
time points (eight in M600, eight in ΔbldA). The remain-
ing 5,983 genes were then analysed for significant (p <
0.05) differential expression between M600 and ΔbldA
using the Welch t-test and Benjamini and Hochberg mul-
tiple testing correction [45].
Rank Product analysis
The preprocessed data (6,457 genes) were imported into
R (Version 2.1.1) [39] for analysis using the RankProd
package [46] with default parameters. Though the micro-
array data produced in this study are two-colour, the use
of a genomic reference allowed the use of the RankProd
package analagously to one-colour data, the values com-
pared being log2 expression ratios of sample_cDNA/
gDNA. Thus, to compare the bldA mutant to M600 at a
particular time point six expression ratios were used, three
from the mutant and three from M600. Rank products
(and associated p-values, probability of false prediction
(pfp) values and average fold-change) for both up- and
down regulation were then calculated by using ranks for
each pairwise comparison of bldA/M600 (i.e. bldA_repA/
M600_repA, bldA_repA/M600_repB, bldA_repA/Page 17 of 22
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comparing the bldA mutant replicates with their respective
M600 counterparts. Differentially expressed up- and
down-regulated genes were selected if their corresponding
pfp value was ≤ 0.1.
Proteins represented differentially between strains
To test statistically for proteins represented differentially
between M600 and ΔbldA the non-parametric Mann-
Whitney U-test was applied, comparing the data based on
their ranks rather than absolute values. All 336 protein
spots were tested for significance of differences between
strains, with p-values being corrected by the Benjamini
and Hochberg procedure. Differences were deemed signif-
icant if the corrected p-value was less than 0.05. It was evi-
dent that using these stringent criteria has the potential to
lose interesting data, particularly spots absent in one
strain and developmentally regulated in the other, since
any protein spot completely absent from one would have
to be present in at least three of the five time-points of the
second strain to be called significantly different (based on
simulations, see below). An additional complementary
mathematical analysis was therefore undertaken in which
protein spots were considered to be differentially repre-
sented between strains if their normalized volumes were
changed two-fold or more in both biological duplicate
growth curves in at least two (of the five) corresponding
time points. The results from both approaches were ulti-
mately combined to produce a master list of differentially
represented proteins, with presence and absence of corre-
sponding P-values indicating which protein spots were
found in the statistical and mathematical analyses, respec-
tively.
Classification of proteins according to their abundance profiles in 
M600
Normalized spot volume measurements for strain M600
samples over time for all 336 identified proteins were
grouped into one of six abundance profile classes by
applying the following set of simple mathematical rules.
If in each replicate the largest value is less than or equal to
the smallest value multiplied by 2, place into Group A
(approximately equal abundance). If this is true only for
one replicate, place in Group F (approximately equal
abundance at each timepoint in one growth series, but not
the other). The remainder exhibit two-fold or more
changes in abundance in both replicates, and are placed
into Group B if they reproducibly exhibit increasing abun-
dance with time, Group C for those decreasing in abun-
dance with time, and Group D for those with an initial
increase followed by a decrease. Any remaining are placed
in Group E (changing, but no reproducible trend). Ten of
the 336 spots were not seen in M600 but were detected in
the bldA mutant, and are given a separate class.
Correlation between transcriptome and proteome
Spearman Rank correlation was used to compare the tran-
scriptome and proteome mainly because it avoids scaling
issues. As a non-parametric method, using the ranking of
values to compute correlation Spearman rank also allows
the use of arbitrary values representing very low abun-
dance proteins. Thus, the Spearman rank correlation r
between transcript and protein was calculated by
where d is the difference between the ranks of protein and
transcript data in sample s and N is the number of sam-
ples.
To test whether the observed Spearman rank correlation
could be obtained by chance a t-test was calculated by
The resultant t-statistic was then converted to a p-value
based on the t-distribution. All p-values were then cor-
rected by application of the Benjamini and Hochberg
multiple testing correction procedure [39,45,47] and were
classed as significant if p < 0.05. Correlation between tran-
scriptome and proteome data was computed for each of
the 5 time-points in each strain (a vector of 310 in each
test) and for each gene across five time-points in M600,
five time-points in ΔbldA and ten time-points across both
M600 and ΔbldA. Analysis was only performed on 310
protein spots, as the other 26 spots did not have corre-
sponding genes that passed through the stringent filtering
applied to the transcriptome data. Where multiple protein
products were identified from a single gene the correla-
tion was calculated using the transcriptomic data for that
gene versus proteomic data for each individual protein
spot (i.e. multiple spots were not averaged or summed),
because of the possibility that not all spots for any one
gene product were detected.
Identification of DNA motifs upstream of differentially expressed 
genes
Initial searches for conserved sequence motifs were con-
ducted on the genes whose transcription was shown
directly by Welch t-test analysis of microarray data to be
influenced by bldA. A sequence set was constructed con-
sisting of 500 nt segments (300 nt upstream and 200 nt
downstream of the translational start codons) of each
gene, in the correct transcriptional orientation (based on
the annotated S. coelicolor genome GenBank
(AL645882)). The sequence set was submitted to the
MEME (Multiple Em for Motif Elicitation) server [48],
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the motif to search for was set to 5 nts; maximum width
to 30 nts; and maximum number of sites to find was set to
10. From the MEME output file an IUPAC consensus
sequence was constructed for each motif. To estimate the
distribution of each motif (i.e. how many genes in the
genome have this motif in their upstream regions) the
MEME-derived consensus sequence was used to search the
S. coelicolor genome sequence for hits within the upstream
regions of all genes (as defined above) using the genome-
scale dna-pattern tool of RSAT (Regulatory Sequence
Analysis Tools; [49]) with default settings except that one
nucleotide substitution was allowed.
Construction of a SCO4263 deletion mutant
A mutant SCO4263 allele, in which the entire coding
region was replaced by an apramycin resistance cassette,
was constructed by PCR-targeting essentially as described
by Gust et al. [50]. Briefly, oligonucleotide primers (5'-)
with 5' ends homologous to the 5' and 3' ends adjacent to
the SCO4263 coding sequence, and 3' (priming) ends
designed to amplify the apramycin resistance disruption
cassette, were used in a PCR with pIJ773 as template. The
PCR product was introduced into E. coli BW25113/pIJ790
containing cosmid StD86A [51], preinduced for λred
functions by the addition of arabinose, to obtain a
SCO4263-disrupted version of the StD86A cosmid. The
disrupted cosmid was introduced into E. coli ET12567/
pUZ8002 by transformation, then transferred into S. coe-
licolor M600 by conjugation. Exconjugants were selected
on MS agar [35] containing apramycin, and the products
of double crossovers identified by screening for kanamy-
cin sensitivity. Deletions were confirmed by PCR and
Southern blotting.
Quantitative real-time PCR analysis of selected differentially 
expressed genes
Specific primers and probes for 14 of the 74 selected dif-
ferentially expressed genes (SCO6808, SCO7657,
SCO4295, SCO5013, SCO3088, SCO3285, SCO3286,
SCO5166, SCO6958, SCO6638, SCO4648, SCO4702,
SCO4705, SCO4717) were designed using either Primer
Express v.2 software (Applied Biosystems) or Primer 3
software [52]. Five μg samples of each of the 16 RNA prep-
arations from replicate 3 were subjected to RNase-free
DNase I treatment (Promega) in a 20 μl reaction volume.
One μg of RNA was used as template for cDNA synthesis
with 225 ng of random hexamers (Invitrogen) and 50
units of Superscript II reverse transcriptase (Invitrogen) in
20 μl reaction volumes, and incubated for 10 min at
25°C, 50 min at 42°C and then 15 min at 70°C. The sam-
ples were diluted 1:4 with distilled water and 5 μl was
used in the quantitative PCR reaction with 10 pmol of for-
ward and reverse primer and 2.5 pmol of FAM/TAMRA
dual-labelled specific probe (Operon technologies) in 25
μl master mix (QPCR ROX, ABgene). Parallel reactions
were performed in the same 96-well plate using different
dilutions of genomic DNA in order to generate a standard
curve for each selected gene. The reactions were analysed
in an ABI PRISM 7000 Sequence Detection System
(Applied Biosystems).
S1 nuclease mapping
RNA was isolated from exponential and transition-phase
cultures as described by Strauch et al. [12]. For each S1
nuclease reaction 20 μg RNA was hybridised in NaTCA
buffer [53] to about 0.2 pmol (approximately 105 Cer-
enkov counts min-1) of each of the following radiola-
belled probes. For SCO4253, the oligonucleotide 5'-
GACCGACGAAGGCCGCCACCGA-3', which anneals
within the SCO4253 coding region, was uniquely end-
labelled at its 5'- end with [γ-32P]-ATP using T4 polynucle-
otide kinase. This was used in the PCR together with the
unlabelled probe 5'-GATCTGACCGATCCTCCT-
GACACGCCGTCACCGT-3' (which anneals upstream of
the SCO4253 gene) and cosmid StD49 as template, to
generate a 432 bp probe. PCR was performed in the pres-
ence of 7% dimethylsulphoxide using the following con-
ditions: 94°C for 4 min followed by 26 cycles of 45 s at
94°C, 45 s at 58°C and 60 s at 72°C, then held at 72°C
for 5 min to finish. The probe for SCO0762 was made in
a similar way, but using 5'- AGGCGATCCTAGTCGAT-
CAAGAAACGCCCAGTTC-3' as the unlabelled primer, 5'-
TCTCTCCGTGCCCCACGGTCAGCA-3' as the labelled
primer, and cosmid StF81 [51] as template. This produced
a 365 bp uniquely end-labelled probe product. Hybridisa-
tions were carried out at 45°C for 14 h after denaturation
at 65°C for 15 min. S1 nuclease digestions and analyses
of RNA-protected fragments were performed as described
previously [54]. High-resolution mapping of the tran-
scription start site of SCO4235 was achieved by generat-
ing a sequencing ladder with the same labelled primer as
was used for the probe, using a Thermo Sequenase cycle
sequencing kit (USB) according to the manufacturer's
instructions.
Quantification of ppGpp and intracellular nucleotides
Extraction and HPLC analysis of ppGpp, ATP and GTP
from S. coelicolor cultures were carried out as described by
Strauch et al. [12].
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Additional file 1
Transcript abundance profiles for all 74 genes identified as being differ-
entially expressed between M600 and M600 ΔbldA. Provides a summary 
of the transcript abundance profiles for all 74 genes identified as being dif-
ferentially expressed between M600 and M600 ΔbldA using DNA micro-
arrays.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S1.pdf]
Additional file 2
Transcription profiles determined for SCO4295, SCO5013, SCO6808, 
SCO7657, SCO 3088, SCO 3285, SCO 3286, SCO 5166, SCO 6958, 
SCO 6638, SCO 4660, SCO 4702 and SCO 4648 using either a) Q-
RT-PCR, or B) DNAmicroarrays. A comparison for a subset of genes of 
transcript abundance profiles determined using DNA microarrays with 
results obtained using quantitative RT-PCR.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S2.pdf]
Additional file 3
A list of ribosomal protein genes present in the S. coelicolor genome, and 
the predicted physical properties of their gene products. Illustrates that the 
vast majority of ribosomal proteins would not be expected to be detected in 
the protomics analysis undertaken in this study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S3.doc]
Additional file 4
Normalized spot volume data for the 336 protein spots identified in the 
proteome analysis. A spreadsheet of quantitative protein spot measure-
ments from the proteome analysis.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S4.xls]
Additional file 5
Summary of the protein spots identified as being differentially represented 
between M600 and M600 ΔbldA. Lists proteins that were found to be sta-
tistically differentially represented between the two strains using the 
Mann-Whitney test; those found to be reproducibly differentially expressed 
using the complementary mathematical approach detailed in the Methods; 
and a combined list summarising all differences. Functional assignments 
are noted, based on KEGG [56], and on the Sanger Institute classifica-
tions [57], and information given on: (a) occurrence of more than one 
gene product per gene; (b) 2-fold up- or down-regulated relative to the 
bldA mutant; and (c) membership of the M600 expression profile group 
(see Additional File 6).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S5.xls]
Additional file 6
Classification of the time-course data for the 336 identified protein spots 
according to their abundance profiles in strain M600. Provides informa-
tion on: (a) occurrence of more than one gene product per gene; (b) 2-fold 
up- or down-regulated relative to the bldA mutant; and (c) P-value for 
any statistically different protein spot observed. A list of all genes for which 
more than one protein spot was identified is also presented.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S6.xls]
Additional file 7
Time-course abundance profiles showing changes in the post-translational 
processing of certain proteins as a result of bldA mutation. Illustrates the 
changes observed in post-translational processing of 11 proteins during 
growth of the wild-type and bldA mutant strains.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S7.pdf]
Additional file 8
Summary of the identification of changes in transcription or protein syn-
thesis from 147 genes as a result of bldA mutation. Functional assign-
ments are noted, based on KEGG [56] and on the Sanger Institute 
classifications [57], and operon membership is also indicated. Differences 
identified from the transcriptome and proteome analyses are listed sepa-
rately, and also combined into a masterlist of all differences. Functional 
assignments are noted, based on KEGG [56] and on the Sanger Institute 
classifications [57]. For the proteome data information is given on: a) 
occurrence of more than one gene product per gene; b) 2-fold up- or down-
regulated relative to the bldA mutant; and c) membership of the M600 
expression profile group (see Additional File 6). Significance P-values are 
given where appropriate.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S8.xls]
Additional file 9
Comparison of transcript and protein abundance profiles for the eleven 
genes identified by both transcriptome and proteome analyses as being dif-
ferentially expressed in the ΔbldA mutant. Compares the transcript and 
protein spot abundance profiles for the eleven genes identified by both 
transcriptome and proteome analysis as being differentially expressed in 
the bldA mutant.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S9.pdf]
Additional file 10
Abundance data for protein spots belonging to genes responsible for the 
production of secondary metabolites in S. coelicolor. Illustrates differen-
tial representation of many proteins associated with secondary metabolite 
production as a result of bldA mutation.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-8-261-S10.pdf]Page 20 of 22
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